Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TechnipFMC (FTI) Research & Development (2016 - 2025)

Historic Research & Development for TechnipFMC (FTI) over the last 10 years, with Q3 2025 value amounting to $22.5 million.

  • TechnipFMC's Research & Development rose 4610.39% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 million, marking a year-over-year increase of 1985.19%. This contributed to the annual value of $73.4 million for FY2024, which is 637.68% up from last year.
  • According to the latest figures from Q3 2025, TechnipFMC's Research & Development is $22.5 million, which was up 4610.39% from $14.1 million recorded in Q2 2025.
  • TechnipFMC's Research & Development's 5-year high stood at $25.2 million during Q4 2024, with a 5-year trough of $11.5 million in Q2 2022.
  • Moreover, its 5-year median value for Research & Development was $17.6 million (2024), whereas its average is $18.1 million.
  • Per our database at Business Quant, TechnipFMC's Research & Development surged by 50000.0% in 2021 and then plummeted by 4010.42% in 2022.
  • Over the past 5 years, TechnipFMC's Research & Development (Quarter) stood at $24.0 million in 2021, then dropped by 8.75% to $21.9 million in 2022, then dropped by 11.87% to $19.3 million in 2023, then skyrocketed by 30.57% to $25.2 million in 2024, then decreased by 10.71% to $22.5 million in 2025.
  • Its Research & Development stands at $22.5 million for Q3 2025, versus $14.1 million for Q2 2025 and $19.1 million for Q1 2025.